EP2806883
BIOMARKERS AND COMBINATION THERAPIES USING ONCOLYTIC VIRUS AND IMMUNOMODULATION
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
25.1.2013EP published:
24.4.2019EP application number:
13706770.8
EPO information:
European Patent Register
Max expiry date:
24.1.2033
Title:
BIOMARKERS AND COMBINATION THERAPIES USING ONCOLYTIC VIRUS AND IMMUNOMODULATION
Timeline
Today
25.1.2013EP application
24.4.2019EP Publication
Owner
Name:
DNAtrix, Inc.Address:
2450 Holcombe Boulevard Suite X+200, 77021, Houston, TX, US
Name:
Board of Regents, The University of Texas SystemAddress:
210 West 7th Street, 78701, Austin, TX, US
Inventor
Name:
TUFARO, FrankAddress:
Rancho Santa Fe, CA, US
Name:
CONRAD, CharlesAddress:
Deceased, US
Name:
FUEYO-MARGARETO, JuanAddress:
Houston, TX, US
Name:
LANG, FrederickAddress:
Houston, TX, US
Name:
GOMEZ-MANZANO, CandelariaAddress:
Houston, TX, US
Name:
YUNG, W.k., AlfredAddress:
Houston, TX, US
Name:
HEIMBERGER, AmyAddress:
Houston, TX, US
Priority
Number:
201261590441 PDate:
25.1.2012Country:
US
Number:
201261637191 PDate:
23.4.2012Country:
US
Classification
Categories:
A61K 38/19, A61K 31/00, C12N 15/86, G01N 33/574